Results for tag: "Becker Muscular Dystrophy Drug"

Becker Muscular Dystrophy (BMD) is a rare genetic disorder that affects the muscles and is caused by a mutation in the dystrophin gene. It is a progressive disorder that can lead to muscle weakness and disability. Treatment for BMD is limited and there is currently no cure. However, there are a number of drugs available to help manage the symptoms of the disorder. These drugs are part of the Central Nervous System (CNS) drug market. CNS drugs are used to treat a variety of neurological disorders, including BMD. These drugs can help reduce muscle weakness, improve mobility, and slow the progression of the disorder. Commonly used drugs for BMD include corticosteroids, anticonvulsants, and immunosuppressants. The CNS drug market is a rapidly growing market, driven by the increasing prevalence of neurological disorders. The market is expected to continue to grow in the coming years as new treatments are developed and approved. Some of the major companies in the BMD drug market include Pfizer, Novartis, Merck, and Sanofi. These companies are actively researching and developing new treatments for BMD and other neurological disorders. Show Less Read more